---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-012666"
form_type: "8-K"
ticker: "ASTH"
cik: "0001083446"
company_name: "Astrana Health, Inc."
filed_at: "2022-05-05T23:59:59+00:00"
generated_at: "2026-06-25T23:19:25.085657+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# ApolloMed Q1 revenue up 50% to $263M; raises FY guidance; appoints new CFO

## Summary
- Q1 revenue $263.3M, up 50% YoY; net income attributable to ApolloMed $14.3M (+8%); adj. EBITDA $38.2M (+25%).
- FY guidance raised: revenue $1,055M–$1,085M; adj. EBITDA $136M–$166M (previous low $130M).
- CFO Eric Chin steps down for personal reasons; Chan Basho appointed Interim CFO and Chief Strategy Officer.
- Basho's compensation: $300k base, $200k sign-on bonus, $1.2M initial restricted stock award.
- Completed acquisition of Jade Health Care Medical Group, adding ~13,000 Medicare/Medicaid members.

## SEC filing metadata
- accession: 0001628280-22-012666
- form_type: 8-K
- ticker: ASTH
- cik: 0001083446
- company_name: Astrana Health, Inc.
- filed_at: 2022-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1083446/000162828022012666/0001628280-22-012666-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1083446/000162828022012666/ameh-20220505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-012666
- JSON: https://secwatch.observer/filing/0001628280-22-012666.json
- Plain text: https://secwatch.observer/filing/0001628280-22-012666.txt

## Key facts
- Executive change
  Eric Chin departed as Chief Financial Officer at Astrana Health, Inc..
  - Action: stepped down
  - Role: Chief Financial Officer
  source text: In connection with the appointment, Eric Chin will step down for personal reasons as Chief Financial Officer effective May 5, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1083446/000162828022012666/0001628280-22-012666-index.htm
- Executive change
  Chan Basho was appointed as Interim Chief Financial Officer at Astrana Health, Inc..
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: On May 5, 2022, the Company appointed Chan Basho as the Company's Interim Chief Financial Officer, effective May 5, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1083446/000162828022012666/0001628280-22-012666-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.